Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

New agents for IBS from Nippon Shinyaku

Feb. 11, 1998

Maxamine/Infergen combination to be tested in clinic

Feb. 9, 1998

EMEA decision on Zacutex MAA deferred

Feb. 9, 1998

Schering-Plough discloses HCV NS3 protease inhibitors

Feb. 9, 1998

K+ channel blockers patented by HMR for ulcers, arrhythmias

Feb. 9, 1998

Pharmacia & Upjohn and Chiron establish HCV collaboration

Feb. 4, 1998

Prokinetic motilin agonists in development at Ohmeda

Jan. 30, 1998

Meiji Seika describes 5-HT3 partial agonists for GI disorders

Jan. 29, 1998

Vion prepares more active prodrug of beta-L-FD4C

Jan. 27, 1998

Randomized trial compares interferon alfa-2b + ribavirin to interferon alone for HCV

Jan. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...